Active 0 6 0 6 O
central 7 14 7 14 B-cancer
nervous 15 22 15 22 I-cancer
system 23 29 23 29 I-cancer
( 30 31 30 31 I-cancer
CNS 31 34 31 34 I-cancer
) 34 35 34 35 I-cancer
malignant 36 45 36 45 I-cancer
disease 46 53 46 53 I-cancer
in 54 56 54 56 O
subjects 57 65 57 65 O
with 66 70 66 70 O
a 71 72 71 72 O
history 73 80 73 80 O
of 81 83 81 83 O
CNS 84 87 84 87 B-cancer
malignancy 88 98 88 98 I-cancer

Active 0 6 99 105 B-chronic_disease
infection 7 16 106 115 I-chronic_disease
requiring 17 26 116 125 O
intravenous 27 38 126 137 B-treatment
( 39 40 138 139 I-treatment
IV 40 42 139 141 I-treatment
) 42 43 141 142 I-treatment
antibiotic 44 54 143 153 I-treatment
usage 55 60 154 159 O
within 61 67 160 166 O
the 68 71 167 170 O
last 72 76 171 175 O
week 77 81 176 180 O
prior 82 87 181 186 O
to 88 90 187 189 O
the 91 94 190 193 O
dosimetry 95 104 194 203 O
portion 105 112 204 211 O
of 113 115 212 214 O
the 116 119 215 218 O
study 120 125 219 224 O

Adequate 0 8 225 233 O
performance 9 20 234 245 O
status 21 27 246 252 O
: 27 28 252 253 O
Eastern 29 36 254 261 B-clinical_variable
Cooperative 37 48 262 273 I-clinical_variable
Oncology 49 57 274 282 I-clinical_variable
Group 58 63 283 288 I-clinical_variable
( 64 65 289 290 I-clinical_variable
ECOG 65 69 290 294 I-clinical_variable
) 69 70 294 295 I-clinical_variable
≤ 71 72 296 297 O
2 73 74 298 299 B-upper_bound

Archival 0 8 300 308 B-cancer
tumor 9 14 309 314 I-cancer
sample 15 21 315 321 O
available 22 31 322 331 O
, 31 32 331 332 O
or 33 35 333 335 O
be 36 38 336 338 O
willing 39 46 339 346 O
to 47 49 347 349 O
undergo 50 57 350 357 O
a 58 59 358 359 O
fresh 60 65 360 365 B-treatment
tumor 66 71 366 371 I-treatment
biopsy 72 78 372 378 I-treatment
, 78 79 378 379 O
prior 80 85 380 385 O
to 86 88 386 388 O
study 89 94 389 394 O

At 0 2 395 397 O
least 3 8 398 403 O
4 9 10 404 405 B-lower_bound
weeks 11 16 406 411 I-lower_bound
beyond 17 23 412 418 O
the 24 27 419 422 O
last 28 32 423 427 O
chemotherapy 33 45 428 440 B-treatment
( 46 47 441 442 O
or 47 49 442 444 O
≥ 50 51 445 446 O
5 52 53 447 448 B-lower_bound
half 54 58 449 453 O
- 58 59 453 454 O
lives 59 64 454 459 O
for 65 68 460 463 O
targeted 69 77 464 472 O
agents 78 84 473 479 O
, 84 85 479 480 O
whichever 86 95 481 490 O
is 96 98 491 493 O
shorter 99 106 494 501 O
) 106 107 501 502 O
, 107 108 502 503 O
radiotherapy 109 121 504 516 B-treatment
, 121 122 516 517 O
major 123 128 518 523 B-treatment
surgery 129 136 524 531 I-treatment
or 137 139 532 534 O
experimental 140 152 535 547 B-treatment
treatment 153 162 548 557 I-treatment
and 163 166 558 561 O
recovered 167 176 562 571 O
from 177 181 572 576 O
all 182 185 577 580 O
acute 186 191 581 586 O
toxicities 192 202 587 597 O
( 203 204 598 599 O
≤ 204 205 599 600 O
Grade 206 211 601 606 B-upper_bound
1 212 213 607 608 I-upper_bound
) 213 214 608 609 O

At 0 2 610 612 O
least 3 8 613 618 O
one 9 12 619 622 B-lower_bound
measurable 13 23 623 633 O
disease 24 31 634 641 O
site 32 36 642 646 O
that 37 41 647 651 O
meets 42 47 652 657 O
target 48 54 658 664 O
lesion 55 61 665 671 O
requirements 62 74 672 684 O

Concomitant 0 11 685 696 B-treatment
medication(s 12 24 697 709 I-treatment
) 24 25 709 710 I-treatment
that 26 30 711 715 O
may 31 34 716 719 O
cause 35 40 720 725 O
QTc 41 44 726 729 B-chronic_disease
prolongation 45 57 730 742 I-chronic_disease
or 58 60 743 745 O
induce 61 67 746 752 O
Torsades 68 76 753 761 B-chronic_disease
de 77 79 762 764 I-chronic_disease
Pointes 80 87 765 772 I-chronic_disease
, 87 88 772 773 O
with 89 93 774 778 O
the 94 97 779 782 O
exception 98 107 783 792 O
of 108 110 793 795 O
antimicrobials 111 125 796 810 B-treatment
that 126 130 811 815 O
are 131 134 816 819 O
considered 135 145 820 830 O
to 146 148 831 833 O
be 149 151 834 836 O
essential 152 161 837 846 O
for 162 165 847 850 O
care 166 170 851 855 O
of 171 173 856 858 O
the 174 177 859 862 O
patient 178 185 863 870 O

Corticosteroid 0 14 871 885 B-treatment
use 15 18 886 889 O
within 19 25 890 896 O
2 26 27 897 898 B-upper_bound
weeks 28 33 899 904 I-upper_bound
of 34 36 905 907 O
study 37 42 908 913 O
treatment 43 52 914 923 O

Expansion 0 9 924 933 O
Phase 10 15 934 939 O
: 15 16 939 940 O
P 17 18 941 942 B-cancer
- 18 19 942 943 I-cancer
cadherin 19 27 943 951 I-cancer
positive 28 36 952 960 I-cancer
tumor 37 42 961 966 I-cancer
expression 43 53 967 977 O

Histologically 0 14 978 992 O
or 15 17 993 995 O
cytologically 18 31 996 1009 O
confirmed 32 41 1010 1019 O
advanced 42 50 1020 1028 O
solid 51 56 1029 1034 B-cancer
tumor 57 62 1035 1040 I-cancer
malignancy 63 73 1041 1051 I-cancer
, 73 74 1051 1052 O
refractory 75 85 1053 1063 O
or 86 88 1064 1066 O
relapsed 89 97 1067 1075 O
from 98 102 1076 1080 O
prior 103 108 1081 1086 B-treatment
therapy 109 116 1087 1094 I-treatment
, 116 117 1094 1095 O
or 118 120 1096 1098 O
for 121 124 1099 1102 O
whom 125 129 1103 1107 O
no 130 132 1108 1110 O
alternative 133 144 1111 1122 O
therapy 145 152 1123 1130 O
is 153 155 1131 1133 O
available 156 165 1134 1143 O

History 0 7 1144 1151 O
of 8 10 1152 1154 O
retinal 11 18 1155 1162 B-chronic_disease
degenerative 19 31 1163 1175 I-chronic_disease
disease 32 39 1176 1183 I-chronic_disease
, 39 40 1183 1184 O
history 41 48 1185 1192 O
of 49 51 1193 1195 O
uveitis 52 59 1196 1203 B-chronic_disease
, 59 60 1203 1204 O
history 61 68 1205 1212 O
of 69 71 1213 1215 O
retinal 72 79 1216 1223 B-chronic_disease
vein 80 84 1224 1228 I-chronic_disease
occlusion 85 94 1229 1238 I-chronic_disease
( 95 96 1239 1240 I-chronic_disease
RVO 96 99 1240 1243 I-chronic_disease
) 99 100 1243 1244 I-chronic_disease
, 100 101 1244 1245 O
or 102 104 1246 1248 O
any 105 108 1249 1252 O
eye 109 112 1253 1256 O
condition 113 122 1257 1266 O
that 123 127 1267 1271 O
would 128 133 1272 1277 O
be 134 136 1278 1280 O
considered 137 147 1281 1291 O
a 148 149 1292 1293 O
risk 150 154 1294 1298 O
factor 155 161 1299 1305 O
for 162 165 1306 1309 O
RVO 166 169 1310 1313 O
or 170 172 1314 1316 O
has 173 176 1317 1320 O
medically 177 186 1321 1330 O
relevant 187 195 1331 1339 O
abnormalities 196 209 1340 1353 O

Life 0 4 1354 1358 B-clinical_variable
expectancy 5 15 1359 1369 I-clinical_variable
of 16 18 1370 1372 O
≥ 19 20 1373 1374 O
3 21 22 1375 1376 B-lower_bound
months 23 29 1377 1383 I-lower_bound

Males 0 5 1384 1389 B-gender

Negative 0 8 1390 1398 B-pregnancy
serum 9 14 1399 1404 I-pregnancy
pregnancy 15 24 1405 1414 I-pregnancy
test 25 29 1415 1419 O

Pregnant 0 8 1420 1428 B-pregnancy

Previous 0 8 1429 1437 O
antibody 9 17 1438 1446 B-treatment
- 17 18 1446 1447 I-treatment
based 18 23 1447 1452 I-treatment
therapy 24 31 1453 1460 I-treatment
is 32 34 1461 1463 O
allowed 35 42 1464 1471 O
as 43 45 1472 1474 O
long 46 50 1475 1479 O
as 51 53 1480 1482 O
≥ 54 55 1483 1484 O
28 56 58 1485 1487 B-lower_bound
days 59 63 1488 1492 I-lower_bound
has 64 67 1493 1496 O
elapsed 68 75 1497 1504 O
from 76 80 1505 1509 O
last 81 85 1510 1514 O
dose 86 90 1515 1519 O
to 91 93 1520 1522 O
study 94 99 1523 1528 O
treatment 100 109 1529 1538 O

Previous 0 8 1539 1547 O
radioimmunotherapy 9 27 1548 1566 B-treatment

Prior 0 5 1567 1572 B-treatment
radiation 6 15 1573 1582 I-treatment
to 16 18 1583 1585 O
> 19 20 1586 1587 O
30 21 23 1588 1590 B-lower_bound
% 23 24 1590 1591 I-lower_bound
of 25 27 1592 1594 O
the 28 31 1595 1598 O
red 32 35 1599 1602 B-clinical_variable
marrow 36 42 1603 1609 I-clinical_variable
or 43 45 1610 1612 O
to 46 48 1613 1615 O
maximal 49 56 1616 1623 O
tolerable 57 66 1624 1633 O
level 67 72 1634 1639 O
for 73 76 1640 1643 O
any 77 80 1644 1647 O
organ 81 86 1648 1653 O

Serious 0 7 1654 1661 O
cardiac 8 15 1662 1669 B-chronic_disease
condition 16 25 1670 1679 I-chronic_disease
within 26 32 1680 1686 O
the 33 36 1687 1690 O
last 37 41 1691 1695 B-upper_bound
6 42 43 1696 1697 I-upper_bound
months 44 50 1698 1704 I-upper_bound

autoimmune 0 10 1705 1715 B-chronic_disease
disease 11 18 1716 1723 I-chronic_disease

females 0 7 1724 1731 B-gender

positive 0 8 1732 1740 O
for 9 12 1741 1744 O
human 13 18 1745 1750 B-chronic_disease
immunodeficiency 19 35 1751 1767 I-chronic_disease
virus 36 41 1768 1773 I-chronic_disease
( 42 43 1774 1775 I-chronic_disease
HIV 43 46 1775 1778 I-chronic_disease
) 46 47 1778 1779 I-chronic_disease
, 47 48 1779 1780 O
hepatitis 49 58 1781 1790 B-chronic_disease
B 59 60 1791 1792 I-chronic_disease
virus 61 66 1793 1798 I-chronic_disease
surface 67 74 1799 1806 I-chronic_disease
antigen 75 82 1807 1814 I-chronic_disease
( 83 84 1815 1816 I-chronic_disease
HBsAg 84 89 1816 1821 I-chronic_disease
) 89 90 1821 1822 I-chronic_disease
or 91 93 1823 1825 O
hepatitis 94 103 1826 1835 B-chronic_disease
C 104 105 1836 1837 I-chronic_disease
virus 106 111 1838 1843 I-chronic_disease
( 112 113 1844 1845 I-chronic_disease
HCV 113 116 1845 1848 I-chronic_disease
) 116 117 1848 1849 I-chronic_disease

≥ 0 1 1850 1851 O
18 2 4 1852 1854 B-lower_bound
years 5 10 1855 1860 I-lower_bound
of 11 13 1861 1863 O
age 14 17 1864 1867 B-age

